• Mashup Score: 0
    Home | KCJ - 1 year(s) ago

    Aberrant hypoxia signaling orchestrates metabolic reprogramming in clear cell renal cell carcinoma to support glycogen and lipid accumulation.

    Tweet Tweets with this article
    • LATEST: 👉Cytoreductive Nephrectomy for met-RCC in the Era of ICI 👉The Impact of Endogenous Retroviruses in ccRCC 👉Mechanisms of Palliative Care in Treatment of RCC 👉HIF Pathway Inhibition hold much promise 👉KCJ Journal Club Read More https://t.co/k1lvB97lVF #KidneyCancer https://t.co/IdzhXDL3t1

  • Mashup Score: 2

    ABSTRACT Renal mass in a solitary kidney is a challenging clinical scenario and partial nephrectomy (PN) is generally prioritized. For tumors with high complexity, an in vivo approach with hypothermia is most often preferred at our center. Ex vivo PN is another option although results with this approach have varied and its utility in this setting is not well defined. We present the case of a…

    Tweet Tweets with this article
    • 🚨Just In: Ex-Vivo Partial Nephrectomy in a Solitary Kidney. https://t.co/OIoGu6UU8E Award Winning surgical video: ⭕️https://t.co/Ux898Q7c9a @SCampbellMDPhD @rebeccampbell50 @martin_hofmann_ @Jason_yc_Lin @CleClinicUro @Jason_yc_Lin @APitaMD @AmerUrological @Uroweb @UroOnc https://t.co/1QmcLK7mH9

  • Mashup Score: 1
    Home | KCJ - 1 year(s) ago

    × Subscription Sign Up Sign Up Feel free to choose as many as you like. Newsletter Print Copy of KCJ electronic KCJ Terms of Service * Agree to…

    Tweet Tweets with this article
    • LATEST: 👉Ex-Vivo PN in a Solitary Kidney 👉Robotic-assisted cPN for msRCC following IO 👉ASCO 2023 Kidney Cancer Roundup 👉 2023 ASCO Meeting Summary 👉ASCO 2023 - Recommended Abstracts 👉 KCJ Journal Club Read More👉 https://t.co/k1lvB97lVF https://t.co/fOt3wh40UB

  • Mashup Score: 2
    Home | KCJ - 2 year(s) ago

    × Subscription Sign Up Sign Up Feel free to choose as many as you like. Newsletter Print Copy of KCJ electronic KCJ Terms of Service * Agree to…

    Tweet Tweets with this article
    • LATEST: - Management of Chromophobe RCC with NIVO+IPI -ICIs in RCC: Impact of Nutritional Status, Inflammation & Body Composition - Practice-Changing Cancer Trials at #GU23 #GU23 Meeting Summary #GU23 - Recommended Abstracts Read More👉 https://t.co/IyAAAhoVCX https://t.co/HpRRUgvCAP

  • Mashup Score: 1

    Submitted – October 18, 2022 | Revised December 4, 2022 Accepted – December 7, 2022 | | ePublished – December 31, 2022 https://doi.org/10.52733/KCJ21n1-r1 ABSTRACT Renal Cell Carcinoma (RCC) is among the most frequently…

    Tweet Tweets with this article
    • 🚨Just in: Immune Checkpoint Inhibitors in RCC: Examining the Impact of Nutritional Status, Inflammation, & Body Composition by @virajmaster's team 👉https://t.co/gV58zvi26C https://t.co/VBaqWo3S8Q

  • Mashup Score: 1

    Submitted – Februray 14, 2023 | Revised March 9, 2023 | Revised Manuscript Accepted – March 15, 2023 | ePublished – March 30, 2023 https://doi.org/10.52733/KCJ21n1-a1 ABSTRACT Chromophobe renal cell carcinoma (chRCC) is a rare histologic…

    Tweet Tweets with this article
    • 🚨JUST IN: CASE STUDY: Successful Management of Metastatic Chromophobe RCC with NIVO + IPI by @RohanGarjeMD team 📷 https://t.co/OKJw94YQ2Q #ChromophobeRCC #KidneyCancer #RCC https://t.co/jg6IDt3ql9

  • Mashup Score: 0

    × Subscription Sign Up Sign Up Feel free to choose as many as you like. Newsletter Print Copy of KCJ electronic KCJ Terms of Service * Agree to…

    Tweet Tweets with this article
    • @KidneyCancerJ provides immediate #OpenAccess to make research & conference info freely available to ensure a global exchange of knowledge. #NoSubmissionFee Accessed by more than 25,000 HCPs worldwide. #ServingFor20Years 🚨 SUBMIT Your Manuscript: 👉https://t.co/H9Gw4wajOo https://t.co/jjKPLCUpnP